Maynard Um
-
-
-
-
-
-
-
Maxim Group Downgrades VistaGen Therapeutics (VTGN) to Hold
-
-
-
-
-
-
-
VistaGen Therapeutics (VTGN) reported Q2 revenue
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on VistaGen Therapeutics (VTGN)
-
431,638 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

